Asston Pharmaceuticals held an Extraordinary General Meeting on 28 April 2026 via video conference to address key corporate matters.
Shareholders voted on appointing M/s Panchal SK & Associates as statutory auditors following the resignation of M/s Doshi Doshi & Co.
The meeting featured attendance from 8 directors including the Managing Director and key managerial personnel, with remote e-voting conducted through NSDL.
Voting results and scrutinizer's report will be disclosed to BSE and published on company website within two working days post-meeting.